4-Bromobenzylamine structure
|
Common Name | 4-Bromobenzylamine | ||
---|---|---|---|---|
CAS Number | 3959-07-7 | Molecular Weight | 186.049 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 248.9±15.0 °C at 760 mmHg | |
Molecular Formula | C7H8BrN | Melting Point | 25 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 104.3±20.4 °C | |
Symbol |
GHS05 |
Signal Word | Danger |
Name | 4-Bromobenzylamine |
---|---|
Synonym | More Synonyms |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 248.9±15.0 °C at 760 mmHg |
Melting Point | 25 °C(lit.) |
Molecular Formula | C7H8BrN |
Molecular Weight | 186.049 |
Flash Point | 104.3±20.4 °C |
Exact Mass | 184.984009 |
PSA | 26.02000 |
LogP | 1.86 |
Vapour Pressure | 0.0±0.5 mmHg at 25°C |
Index of Refraction | 1.590 |
Symbol |
GHS05 |
---|---|
Signal Word | Danger |
Hazard Statements | H314 |
Precautionary Statements | P280-P305 + P351 + P338-P310 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | C:Corrosive; |
Risk Phrases | R21/22;R34 |
Safety Phrases | S26-S28-S36/37/39-S45 |
RIDADR | UN 3259 8/PG 2 |
WGK Germany | 3 |
Precursor 10 | |
---|---|
DownStream 9 | |
Prokaryotic NavMs channel as a structural and functional model for eukaryotic sodium channel antagonism.
Proc. Natl. Acad. Sci. U. S. A. 111(23) , 8428-33, (2014) Voltage-gated sodium channels are important targets for the development of pharmaceutical drugs, because mutations in different human sodium channel isoforms have causal relationships with a range of ... |
|
Common metal of copper(0) as an efficient catalyst for preparation of nitriles and imines by controlling additives.
Chem. Commun. (Camb.) 50(42) , 5637-40, (2014) A novel, efficient, convenient and environmentally friendly approach for the synthesis of nitriles and imines from primary amines has been developed. Using commercially available red copper as the cat... |
|
Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity.
Bioorg. Med. Chem. 15(11) , 3896-911, (2007) We have designed and synthesized two novel series of MCH-R1 antagonists based on a substituted biphenylmethyl urea core. SAR was explored, suggesting that optimal binding with the receptor was achieve... |
p-Bromobenzylamine |
4-Bromobenzylamine |
1-(4-Bromophenyl)methanamine |
Benzenemethanamine, 4-bromo- |
EINECS 223-559-4 |
MFCD00047931 |
(4-bromophenyl)methanamine |